Viridian TherapeuticsVRDN
13F holders, Q1 2025 (March 31)176holders −2
23new positions
27sold out
7famous investors
$13.48avg. 13F price*
At the end of Q1 2025, 176 institutions reported holding Viridian Therapeutics Inc. (VRDN) in their 13F filings, down 2 from Q4 2024. 23 opened new positions and 27 sold out. The largest holders were FMR LLC ($164.8M), BlackRock, Inc. ($76.9M) and Deep Track Capital, LP ($72.5M). 7 famous investors held it, including Lee Ainslie (0.5% of Maverick Capital's portfolio), Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Viridian Therapeutics Inc.
- CUSIP
- 92790C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 23 | $33.4M |
| Exits | 27 | $42.6M |
All 13F filers, Q4 2024 → Q1 2025: 9,975,822 shares bought and 9,282,734 shares sold, net +693,088 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 176 holders
| FMR LLC | 0.01% | Add +2.9% | 12,222,986 | $164.8M |
| BlackRock, Inc. | 0.00% | Reduce -0.9% | 5,708,110 | $76.9M |
| Deep Track Capital, LP | 2.35% | Add +19.0% | 5,380,449 | $72.5M |
| Kynam Capital Management, LP | 5.42% | Add +41.3% | 4,700,000 | $63.4M |
| Vanguard Group Inc. | 0.00% | Reduce -0.7% | 4,563,100 | $61.5M |
| Venrock Adviser, LLC | 4.45% | No change | 3,882,709 | $52.3M |
| Commodore Capital LP | 3.58% | Add +50.0% | 3,600,000 | $48.5M |
| Fairmount Funds Management LLC | 7.21% | No change | 3,445,813 | $46.4M |
| State Street Corp. | 0.00% | Reduce -18.6% | 2,865,500 | $38.6M |
| Tang Capital Management LLC | 2.08% | Add +12.0% | 2,792,925 | $37.6M |
| Novo Holdings A/S | 2.31% | Add +0.0% | 2,250,300 | $30.3M |
| Paradigm Biocapital Advisors LP | 1.30% | Add +15.1% | 2,095,079 | $28.2M |
| Maverick Capital | 0.50% | Add +0.4% | 2,061,274 | $27.8M |
| Alliancebernstein L.P. | 0.01% | Reduce -11.6% | 2,021,619 | $27.3M |
| Geode Capital Management, LLC | 0.00% | Add +3.7% | 1,720,525 | $23.2M |
| T. Rowe Price Associates Inc. | 0.00% | Add +27.2% | 1,688,129 | $22.8M |
| Eversept Partners, LP | 2.10% | Add +76.6% | 1,377,674 | $18.6M |
| Loomis Sayles & Co. L P | 0.03% | Reduce -2.1% | 1,370,356 | $18.5M |
| Driehaus Capital Management LLC | 0.17% | Reduce -32.3% | 1,270,481 | $17.1M |
| Pictet Asset Management Holding SA | 0.02% | No change | 1,248,721 | $16.8M |
| Goldman Sachs Group Inc. | 0.00% | Add +33.8% | 1,231,092 | $16.6M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | Reduce -33.3% | 1,114,586 | $15.0M |
| Marshall Wace, LLP | 0.02% | New | 1,084,040 | $14.6M |
| Parkman Healthcare Partners LLC | 1.70% | Reduce -2.1% | 1,064,506 | $14.3M |
| Vivo Capital, LLC | 1.75% | No change | 982,576 | $13.2M |
| Candriam S.C.A. | 0.07% | Add +20.4% | 880,430 | $11.9M |
| Woodline Partners LP | 0.07% | No change | 813,647 | $11.0M |
| Great Point Partners LLC | 5.50% | No change | 750,000 | $10.1M |
| 5AM Venture Management, LLC | 3.76% | No change | 736,595 | $9.9M |
| Northern Trust Corp. | 0.00% | Add +1.2% | 702,517 | $9.5M |
| Perceptive Advisors LLC | 0.32% | Reduce -55.6% | 659,662 | $8.9M |
| Rosalind Advisors, Inc. | 3.91% | New | 595,000 | $8.0M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -1.6% | 565,963 | $7.6M |
| Victory Capital Management Inc. | 0.01% | Add +34.7% | 552,850 | $7.5M |
| Fisher Asset Management | 0.00% | Add +3.7% | 537,024 | $7.2M |
| UBS Group AG | 0.00% | Reduce -1.5% | 504,185 | $6.8M |
| Yiheng Capital Management, L.P. | 2.37% | Reduce -33.3% | 500,261 | $6.7M |
| Ikarian Capital, LLC | 2.17% | Add +5.3% | 494,949 | $6.7M |
| Octagon Capital Advisors LP | 1.32% | Reduce -48.3% | 450,000 | $6.1M |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 1.18% | No change | 423,272 | $5.7M |
| Deutsche Bank AG | 0.00% | Reduce -1.5% | 396,808 | $5.3M |
| Affinity Asset Advisors, LLC | 0.87% | Add +144.3% | 390,000 | $5.3M |
| Rice Hall James & Associates, LLC | 0.29% | Add +579.9% | 362,893 | $4.9M |
| Panagora Asset Management Inc. | 0.02% | Add +40.2% | 354,739 | $4.8M |
| Morgan Stanley | 0.00% | Reduce -53.8% | 341,795 | $4.6M |
| Renaissance Technologies | 0.01% | Reduce -13.7% | 320,300 | $4.3M |
| Raymond James Financial Inc. | 0.00% | Add +1.4% | 318,240 | $4.3M |
| JPMorgan Chase & Co. | 0.00% | Reduce -1.9% | 298,550 | $4.0M |
| Millennium Management | 0.00% | Reduce -18.6% | 297,966 | $4.0M |
| Wellington Management Group LLP | 0.00% | Add +11.0% | 249,170 | $3.4M |
| Nuveen, LLC | 0.00% | — | 248,628 | $3.4M |
| Two Sigma Investments, LP | 0.01% | Reduce -47.6% | 222,399 | $3.0M |
| Exome Asset Management LLC | 2.62% | New | 217,294 | $2.9M |
| Principal Financial Group Inc. | 0.00% | Add +17.0% | 208,836 | $2.8M |
| Kopp Family Office, LLC | 1.91% | No change | 205,407 | $2.8M |
| Point72 Asset Management | 0.01% | New | 204,702 | $2.8M |
| Hennion & Walsh Asset Management, Inc. | 0.12% | Reduce -5.5% | 199,193 | $2.7M |
| Russell Investments Group, Ltd. | 0.00% | Reduce -47.8% | 198,258 | $2.7M |
| Bank of New York Mellon Corp | 0.00% | Add +0.8% | 198,177 | $2.7M |
| Two Sigma Advisers, LP | 0.01% | Reduce -42.4% | 193,300 | $2.6M |
| HighVista Strategies LLC | 0.94% | Add +16.8% | 180,551 | $2.4M |
| Bank of America Corp. | 0.00% | Reduce -27.1% | 180,123 | $2.4M |
| Susquehanna Fundamental Investments, LLC | 0.04% | New | 177,166 | $2.4M |
| Diadema Partners LP | 1.75% | Add +227.6% | 162,063 | $2.2M |
| Macquarie Group Ltd. | 0.00% | Add +13.0% | 160,948 | $2.2M |
| Artia Global Partners LP | 0.63% | Add +60.0% | 160,000 | $2.2M |
| Boothbay Fund Management, LLC | 0.07% | Add +5.4% | 145,318 | $2.0M |
| BNP Paribas Financial Markets | 0.00% | Reduce -31.9% | 138,864 | $1.9M |
| Citigroup Inc. | 0.00% | Reduce -0.4% | 135,414 | $1.8M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +12.8% | 130,570 | $1.8M |
| Barclays PLC | 0.00% | Reduce -21.4% | 124,063 | $1.7M |
| American Century Companies Inc. | 0.00% | Add +8.2% | 122,892 | $1.7M |
| J. Goldman & Co LP | 0.06% | Reduce -33.9% | 118,594 | $1.6M |
| Dark Forest Capital Management LP | 0.07% | Add +755.5% | 113,646 | $1.5M |
| Susquehanna International Group, LLP | 0.00% | Add +14.7% | 109,984 | $1.5M |
| Swiss National Bank | 0.00% | Reduce -4.5% | 107,500 | $1.4M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.04% | Add +140.1% | 107,088 | $1.4M |
| Rafferty Asset Management, LLC | 0.01% | Reduce -38.8% | 105,874 | $1.4M |
| Rhumbline Advisers | 0.00% | Add +4.6% | 104,559 | $1.4M |
| Walleye Capital LLC | 0.02% | Reduce -78.4% | 104,017 | $1.4M |
| Squarepoint Ops LLC | 0.00% | Add +198.8% | 99,372 | $1.3M |
| Merck & Co., Inc. | 0.77% | No change | 93,414 | $1.3M |
| Citadel Advisors | 0.00% | Reduce -75.3% | 88,547 | $1.2M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -87.8% | 81,509 | $1.1M |
| D. E. Shaw & Co. | 0.00% | Reduce -81.6% | 81,383 | $1.1M |
| ADAR1 Capital Management, LLC | 0.21% | Add +203.8% | 79,000 | $1.1M |
| Wells Fargo & Company | 0.00% | Add +18.4% | 76,333 | $1.0M |
| Jane Street Group, LLC | 0.00% | Add +56.6% | 75,186 | $1.0M |
| J. Safra Sarasin Holding AG | 0.02% | Add +99.4% | 72,672 | $980K |
| BIT Capital GmbH | 0.12% | Reduce -74.9% | 71,680 | $966K |
| Prelude Capital Management, LLC | 0.09% | New | 67,669 | $912K |
| DCF Advisers, LLC | 0.45% | Add +108.5% | 62,029 | $836K |
| Intech Investment Management LLC | 0.01% | Add +55.7% | 61,628 | $831K |
| Alps Advisors Inc. | 0.00% | Reduce -4.0% | 61,478 | $829K |
| Manufacturers Life Insurance Company, The | 0.00% | Add +21.1% | 60,235 | $812K |
| Legal & General Group Plc | 0.00% | Add +0.0% | 60,215 | $812K |
| Knights of Columbus Asset Advisors LLC | 0.06% | Add +2.7% | 59,281 | $799K |
| Ameriprise Financial Inc. | 0.00% | Add +19.4% | 58,271 | $785K |
| Moody Aldrich Partners LLC | 0.16% | Reduce -1.4% | 57,841 | $780K |
| California State Teachers Retirement System | 0.00% | No change | 54,710 | $737K |
"% of holder's portfolio" is VRDN's weight in each manager's 13F, not the share of Viridian Therapeutics Inc. the manager owns.